b-Neuraminic acid, N-acetyl-,methyl ester, monohydrate (9CI)(CAS: 50998-13-5)

Regulatory guidelines for b-Neuraminic acid, N-acetyl-,methyl ester, monohydrate (CAS: 50998-13-5) include GHS classification for hazardous chemicals, REACH regulations for European manufacturers and importers, and FDA/EPA requirements for its use in pharmaceuticals and chemicals. Specific handling and disposal guidelines must also comply with local environmental protection laws.

Alternatives to b-Neuraminic acid, N-acetyl-,methyl ester, monohydrate (CAS: 50998-13-5) in synthesis include other sialic acid derivatives such as N-glycolylneuraminic acid and other N-acetyl derivatives. Common alternative reagents include N-acetylmannosamine and N-acetylglucosamine.

The market trend for b-Neuraminic acid, N-acetyl-,methyl ester, monohydrate (CAS: 50998-13-5) is driven by increasing research in pharmaceuticals due to its role in immune modulation and antiviral properties. Recent research focuses on its use in vaccine adjuvants and as a therapeutic agent for neurological disorders.

Waste containing b-Neuraminic acid, N-acetyl-,methyl ester, monohydrate (CAS: 50998-13-5) should be collected in appropriate containers, labeled for hazardous waste, and disposed of through professional waste disposal services. Incineration is a common method, but ensure compliance with local environmental regulations to minimize environmental impact.